Amir Kalali
InvestorDirector; Science and Technology Committee Member; Co-Chair Nominating and Corporate Governance Committee at atai Life Sciences
San Diego, California, United States
About
Amir Kalali is a physician-scientist working at the intersection of life sciences and technology, serving as a board director and advisor to private and public companies, universities, and investment groups. He is a Professor of Psychiatry at the University of California San Diego, Editor of Innovations in Clinical Neuroscience, and Lead Editor of Essential CNS Drug Development, with over 250 peer-reviewed publications. He previously led the Neuroscience Center of Excellence at Quintiles (now IQVIA) for nearly 20 years and co-chairs the Decentralized Trials and Research Alliance while chairing the CNS Summit.
Experience
- Multiple Biopharma and technology CompaniesBoard Member and Executive Advisorcurrent2017 — present
- AtaiBeckleyMember Of The Supervisory Boardcurrent2021 — present
- CNS SummitFounder, Chief Curator and Chairmancurrent2010 — present
- Decentralized Trials & Research Alliance (DTRA)Co-Chair and Foundercurrent2020 — present
- University of California, San DiegoProfessorcurrent2007 — present
Education
- UCLMD, Medicine1983 — 1988
Skills & more
+11 more
Medical AffairsR&DDrug DiscoveryProduct DevelopmentMedical EducationRegulatory AffairsMedicineProtocolPharmaceutical IndustryDigital MedicineCROFrom Amir's professional profile.
Colleagues at atai Life Sciences
Frequently asked questions
- Where does Amir Kalali work?
- Amir Kalali is Director; Science and Technology Committee Member; Co-Chair Nominating and Corporate Governance Committee at atai Life Sciences.
Same school
Shared employers
Also worked at University of California, San Diego67
+ 61 more